Retension Pharma Insider Moves Show Confidence: B Group Holds 833,333 Shares
Investor insight: B Group’s stake in Retension Pharma signals confidence, with CEO option exercise boosting insider holdings amid a stable $14.07 price and positive sentiment.
3 minutes to read